Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BMY compared with GSK: revenue, margins and what each company keeps, and the suppliers and customers both name
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
GSK
GSK plc
Change
Mkt cap
Revenue
Revenue
vs
Compare
BMY
Bristol Myers Squibb Co
vs
GSK
GSK plc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
BMY
Bristol Myers Squibb Co
Change
62.42
▲
+0.45%
Mkt cap
$127.0B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
GSK
GSK plc
Change
51.28
▼
−0.50%
Regular session
Nov 10 '26
Mkt cap
$111.2B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 10 '26
BMY
Bristol Myers Squibb Co
vs
GSK
GSK plc
62.42
▲
+0.45%
Price
51.28
▼
−0.50%
$127.0B
Mkt cap
$111.2B
Q3 FY26
$13.1B
Revenue
—
FY25
$48.2B
Revenue
—
Change
Change
BMY
62.42
▲
+0.45%
vs
GSK
51.28
▼
−0.50%
Regular session
Nov 10 '26
Co-movers
daily closes · 500d
Method
›
Moved together
BMY
with
GSK
×0.50
co-movement · GSK on BMY · 500d
r 0.53
scale to r 0.75
Shared co-movers
8
with BMY
with GSK
PFE
Pfizer Inc
r 0.58
r 0.53
AMGN
Amgen Inc
r 0.52
r 0.58
NVS
Novartis AG
r 0.49
r 0.64
MRK
Merck & Co., Inc.
r 0.52
r 0.49
JNJ
Johnson & Johnson
r 0.43
r 0.51
BIIB
Biogen Inc.
r 0.45
r 0.41
BMY, solid
GSK, hatched
× = co-movement · β
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes